MetroWilms
Phase 1/2 Recruiting
28 enrolled
64Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/2 Recruiting
91 enrolled
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Recruiting
5,000 enrolled
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 3 Recruiting
720 enrolled
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Phase 2 Recruiting
148 enrolled
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Recruiting
6,035 enrolled
68Ga-PSMA PET in the Renal Cell Carcinoma
Phase NA Recruiting
300 enrolled
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
30 enrolled
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Recruiting
5,950 enrolled
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 1 Recruiting
125 enrolled
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Phase 1/2 Recruiting
100 enrolled
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Recruiting
950 enrolled
DISSRM
Recruiting
600 enrolled
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
307 enrolled
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Phase 1 Recruiting
140 enrolled
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2 Recruiting
87 enrolled
OCCURORTW
Recruiting
2,000 enrolled
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Phase 1/2 Recruiting
224 enrolled
ARC-20
Phase 1 Recruiting
362 enrolled
VERDI
Phase NA Recruiting
1,020 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
BASECAMP-1
Recruiting
200 enrolled
SMILe
Phase 3 Recruiting
220 enrolled
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Phase NA Recruiting
600 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
iCaRe2
Recruiting
999,999 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
Recruiting
53 enrolled
CAMPERR
Recruiting
7,000 enrolled
A Study of HC-7366 in Combination With Belzutifan (WELIREGā¢) in Patients With Renal Cell Carcinoma
Phase 1 Recruiting
80 enrolled
STROKER
Phase 3 Recruiting
252 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
FIT-001
Phase 1 Recruiting
300 enrolled
CD70-targeted immunoPET Imaging of Kidney Cancer
Phase 2 Recruiting
300 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Recruiting
30 enrolled
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Phase NA Recruiting
90 enrolled
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Recruiting
450 enrolled
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Recruiting
39 enrolled
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Phase NA Recruiting
220 enrolled
Decision Aid (DA) for Renal Patients
Phase NA Recruiting
40 enrolled
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Phase 1 Recruiting
120 enrolled
BLUSH
Recruiting
300 enrolled
K3
Phase NA Recruiting
124 enrolled
PP-RECURK
Recruiting
105 enrolled
A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
Phase 2 Recruiting
260 enrolled
Stereotactic Magnetic Resonance Guided Radiation Therapy
Phase NA Recruiting
397 enrolled
Kidney Cancer DNA Registry
Recruiting
750 enrolled
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Recruiting
2,000 enrolled